We are live on
!
Find out more
NC
Nicholas Company Portfolio holdings
AUM
$5.1B
1-Year Est. Return
8.43%
This Fund
S&P 500
This Quarter
Est. Return
+4.79%
1 Year Est. Return
+8.43%
3 Year Est. Return
+54.31%
5 Year Est. Return
+77.46%
10 Year Est. Return
+337.16%
AUM
$4.21B
AUM Growth
+$64.6M
(+1.6%)
Cap. Flow
-$99.3M
Cap. Flow
% of AUM
-2.36%
Top 10 Holdings %
Top 10 Hldgs %
30.14%
Holding
265
New
11
Increased
89
Reduced
79
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CELG
Celgene Corp
CELG
|
+$36.1M |
| 2 |
ADT
ADT Corp
ADT
|
+$34.9M |
| 3 |
Pfizer
PFE
|
+$27.7M |
| 4 |
Chubb
CB
|
+$19.3M |
| 5 |
Johnson Controls International
JCI
|
+$15.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LO
LORILLARD INC COM STK
LO
|
+$79.3M |
| 2 |
MCRS
MICROS SYSTEMS INC
MCRS
|
+$73.6M |
| 3 |
Motorola Solutions
MSI
|
+$51M |
| 4 |
Bausch Health
BHC
|
+$23.5M |
| 5 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$15.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26.94% |
| 2 | Consumer Discretionary | 15.2% |
| 3 | Industrials | 15.12% |
| 4 | Financials | 11.91% |
| 5 | Technology | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
251
Motorola Solutions
MSI
$68.5B
| – | – |
-792,505
| Closed | -$51M |
|
252
Sensient Technologies
SXT
$4.67B
| – | – |
-80,775
| Closed | -$4.56M |
|
253
Teradata
TDC
$2.9B
| – | – |
-90,000
| Closed | -$4.43M |
|
254
TransDigm Group
TDG
$68.3B
| – | – |
-45,045
| Closed | -$8.34M |
|
255
Unilever
UL
$134B
| – | – |
-444
| Closed | -$21K |
|
|
MINI
256
DELISTED
Mobile Mini Inc
MINI
| – | – |
-30,150
| Closed | -$1.31M |
|
|
ELGX
257
DELISTED
Endologix Inc
ELGX
| – | – |
-17,670
| Closed | -$2.27M |
|
|
IMPV
258
DELISTED
Imperva, Inc.
IMPV
| – | – |
-40,330
| Closed | -$2.25M |
|
|
SODA
259
DELISTED
SodaStream International Ltd
SODA
| – | – |
-45,425
| Closed | -$2M |
|
|
MJN
260
DELISTED
Mead Johnson Nutrition Company
MJN
| – | – |
-35,040
| Closed | -$2.91M |
|
|
DTV
261
DELISTED
DIRECTV COM STK (DE)
DTV
| – | – |
-208,085
| Closed | -$15.9M |
|
|
LO
262
DELISTED
LORILLARD INC COM STK
LO
| – | – |
-1,466,560
| Closed | -$79.3M |
|
|
MCRS
263
DELISTED
MICROS SYSTEMS INC
MCRS
| – | – |
-1,389,875
| Closed | -$73.6M |
|
|
ABAX
264
DELISTED
Abaxis Inc
ABAX
| – | – |
-250
| Closed | -$9K |
|
Similar funds
VT
CS
EIC
AC
CIA
TAM
CTC
BG
Nicholas Company's Q2 2014 Portfolio in Review
As of Q2 2014, Nicholas Company held 265 positions worth $4.21B, up 1.6% from $4.14B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Nicholas Company's Q2 2014 filing shows 11 new, 89 increased, 79 reduced and 19 closed positions. Its largest new stake was Celgene Corp: 474,120 shares worth $40.7M. The largest sale was LORILLARD INC COM STK, an estimated $79.3M.
By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Industrials.
- Nicholas Company's largest Q2 2014 buy was Celgene Corp: 474,120 shares worth $40.7M.
- Nicholas Company added most to Pfizer in Q2 2014, an estimated $27.7M increase.
- Nicholas Company's biggest Q2 2014 reduction was Bausch Health, cutting an estimated $23.5M.
- Nicholas Company fully exited LORILLARD INC COM STK in Q2 2014, selling an estimated $79.3M.
- Nicholas Company's ten largest holdings make up 30% of its $4.21B portfolio in Q2 2014.
- Nicholas Company opened 11 new positions and closed 19 in Q2 2014.
- Nicholas Company's portfolio value rose 1.6% quarter-over-quarter to $4.21B.
Based on Nicholas Company's 13F filing for Q2 2014, filed 14 Aug 2014.